ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Clinical trials for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Obesity-Linked endometrial cancer: drug combo enters human trials
Disease control Recruiting nowThis early-phase study tests the safety of combining two drugs, atezolizumab and ONC201, in women with advanced or recurrent endometrial cancer. The trial includes both obese and non-obese participants to see how body weight affects treatment. Up to 58 women will take part, and t…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Targeted therapy combo shows promise in aggressive uterine cancer trial
Disease control Recruiting nowThis study tests whether adding targeted drugs (trastuzumab and pertuzumab) to standard chemotherapy can shrink tumors and stop HER2-positive endometrial cancer from coming back. About 360 people with stage I-IV endometrial cancer will receive either chemo alone or chemo plus the…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Immunotherapy duo shows promise against returning uterine cancer
Disease control Recruiting nowThis study compares two immunotherapy drugs (nivolumab and ipilimumab) against nivolumab alone in people with recurrent endometrial cancer that has a specific DNA repair defect (dMMR). The goal is to see if the combination shrinks tumors better. About 81 participants will receive…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
Shorter radiation may ease burden for early endometrial cancer patients
Symptom relief Recruiting nowThis study compares a shorter course of internal radiation (vaginal cuff brachytherapy) to the standard longer course for people with early-stage endometrial cancer. The goal is to see if the shorter treatment improves quality of life and reduces financial stress. About 188 parti…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 10, 2026 13:29 UTC